Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples